Loading...

BrainsWay Ltd.

BRSYFPNK
Healthcare
Medical - Devices
$5.49
$0.00(0.00%)

BrainsWay Ltd. (BRSYF) Financial Performance & Income Statement Overview

View comprehensive annual and quarterly summaries for BrainsWay Ltd. (BRSYF), featuring income statements, balance sheets, and cash flow data.

Revenue Growth
29.04%
29.04%
Operating Income Growth
128.05%
128.05%
Net Income Growth
169.60%
169.60%
Operating Cash Flow Growth
702.02%
702.02%
Operating Margin
4.05%
4.05%
Gross Margin
74.52%
74.52%
Net Profit Margin
11.60%
11.60%
ROE
8.97%
8.97%
ROIC
2.17%
2.17%

BrainsWay Ltd. (BRSYF) Income Statement & Financial Overview

Analyze BrainsWay Ltd.’s BRSYF earnings with segmented quarterly and yearly financial statement figures.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$11.54M$11.41M$10.50M$10.005M
Cost of Revenue$2.93M$2.90M$2.78M$2.47M
Gross Profit$8.61M$8.51M$7.72M$7.54M
Gross Profit Ratio$0.75$0.75$0.74$0.75
R&D Expenses$2.33M$2.04M$1.81M$1.71M
SG&A Expenses$5.70M$5.07M$5.63M$5.24M
Operating Expenses$8.03M$8.08M$7.44M$6.95M
Total Costs & Expenses$10.96M$10.98M$10.22M$9.42M
Interest Income$1.27M$532000.00$830000.00$518000.00
Interest Expense$586000.00$174000.00$374000.00$401000.00
Depreciation & Amortization$394000.00$708000.00$448000.00$298000.00
EBITDA$2.24M$1.39M$1.56M$884000.00
EBITDA Ratio$0.19$0.12$0.15$0.09
Operating Income$576000.00$431000.00$281000.00$586000.00
Operating Income Ratio$0.05$0.04$0.03$0.06
Other Income/Expenses (Net)$688000.00$1.30M$456000.00$117000.00
Income Before Tax$1.26M$1.74M$737000.00$703000.00
Income Before Tax Ratio$0.11$0.15$0.07$0.07
Income Tax Expense$157000.00$188000.00$75000.00$103000.00
Net Income$1.11M$1.55M$662000.00$600000.00
Net Income Ratio$0.10$0.14$0.06$0.06
EPS$0.03$0.04$0.02$0.02
Diluted EPS$0.02$0.04$0.02$0.02
Weighted Avg Shares Outstanding$36.90M$34.77M$30.00M$30.00M
Weighted Avg Shares Outstanding (Diluted)$36.90M$34.77M$30.00M$30.00M

Over the last four quarters, BrainsWay Ltd. achieved steady financial progress, growing revenue from $10.005M in Q2 2024 to $11.54M in Q1 2025. Gross profit stayed firm with margins at 75% in Q1 2025 versus 75% in Q2 2024. Operating income totaled $576000.00 in Q1 2025, maintaining a 5% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $2.24M. Net income dropped to $1.11M, with EPS at $0.03. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;